Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
This report contains market size and forecasts of Peptide Vaccine in global, including the following market information:
Global Peptide Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Peptide Vaccine companies in 2021 (%)
The global Peptide Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solution Phase Synthesis (SPS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Vaccine include Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck and ImmunoCellular Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Vaccine Market Segment Percentages, by Type, 2021 (%)
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Global Peptide Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Vaccine Market Segment Percentages, by Application, 2021 (%)
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
Global Peptide Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide Vaccine revenues share in global market, 2021 (%)
Key companies Peptide Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Peptide Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax